Positive Airway Pressure, Mortality, and Cardiovascular Risk in Older Adults With Sleep Apnea.

ABSTRACT:

Importance

Positive airway pressure (PAP) is the first-line treatment for obstructive sleep apnea (OSA), but evidence on its beneficial effect on major adverse cardiovascular events (MACE) and mortality prevention is limited.

Objective

To determine whether PAP initiation and utilization are associated with lower mortality and incidence of MACE among older adults with OSA living in the central US.

Design, setting, and participants

This retrospective clinical cohort study included Medicare beneficiaries with 2 or more distinct OSA claims identified from multistate, statewide, multiyear (2011-2020) Medicare fee-for-service claims data. Individuals were followed up until death or censoring on December 31, 2020. Analyses were performed between December 2021 and December 20

SUBMITTER: Mazzotti DR 

PROVIDER: S-EPMC11391331 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature